[1]
J.-W. Shin, “Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study”, Acta Derm Venereol, vol. 99, no. 1, pp. 41–46, Oct. 2018.